Chemiluminescence Immunoassay (CLIA) Analyzers Market is Expected to see a Growth of 6.3 % During the Forecast Period 2017-2025 Exclusive Report by Transparency Market Research Inc.

The global Chemiluminescence Immunoassay (CLIA) Analyzers market is poised for significant growth, propelled by factors such as the high incidence and prevalence of chronic diseases and the increasing demand for laboratory automation. According to Transparency Market Research, the market, valued at US$ 5.04 billion in 2018, is anticipated to expand at a robust CAGR of 6.3% from 2019 to 2027, reaching new heights.

Request your sample copy today: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31517

Competitive Analysis:
Leading players operating in the global chemiluminescence immunoassay (CLIA) analyzers market are -

Abbott
F. Hoffmann-La Roche Ltd
Siemens Healthineers (Siemens AG)
Danaher (Beckman Coulter, Inc.)
DiaSorin S.p.A
Ortho Clinical Diagnostics (Part of Carlyle Group)
Shenzhen New Industries Biomedical Engineering Co., Ltd.
Sysmex Corporation
Randox Laboratories Ltd.
Tosoh Corporation

Driving Forces: Chronic Diseases and Laboratory Automation
Rising Chronic Disease Incidence:
Sedentary lifestyles and unhealthy diets contribute to a surge in chronic diseases globally.
The World Health Organization (WHO) reported an estimated 18.1 million new cancer cases and 9.6 million deaths in 2018 alone.
The aging population and prevalent risk factors like smoking and obesity further escalate chronic disease prevalence.

Laboratory Standardization and Calibration:
Physicians and pathologists focus on standardizing assays to compare test results with established standards.
CLIA instruments, as closed system multiplexed automated analyzers, offer high throughput and ease of calibration, meeting regulatory guidelines.

International Accreditations and Result Comparability:
Growing demand for international accreditations drives the adoption of high-throughput automated immunoassays.
CLIA analyzers' closed-system design and easy calibration contribute to result comparability, meeting the standards set by regulatory authorities.
Technological Advancements: Next-Generation Integrated Immunoassays

Next-Generation Integrated Immunoassays:
Technological trends include the introduction of next-generation integrated immunoassays.
Innovations like Abbott's Alinity ci-series, cleared by the FDA, showcase the

industry's commitment to multiplexed assays.
Expansion of Test Portfolios:
Manufacturers invest in continuous research and development to expand their test portfolios.
Danaher's FDA-cleared Access AMH immunoassay exemplifies the industry's focus on innovative and diverse test offerings.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=31517

Market Challenges: Fragmented Consumables Market
Pricing Pressure and Intensified Competition:
Expansion of test portfolios by emerging market players leads to increased competition.
Local players offering test kits at lower prices affect major manufacturers, imposing pricing pressure and impacting profit margins.

Impact on Geographic Expansion:
Lower-cost alternatives and fragmented consumables markets challenge the geographic expansion of major players.
Competitive Landscape: Key Players and Strategies

Major Players:
Leading players in the global CLIA analyzers market include Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher, DiaSorin S.p.A, and others.

Strategic Developments:
Abbott's contribution to COVID-19 testing through IgG CLIA antibody tests highlights its commitment to public health.
Collaborations, partnerships, and acquisitions, such as DiaSorin partnering with QIAGEN, showcase the industry's dynamic landscape.
The global Chemiluminescence Immunoassay (CLIA) Analyzers market is on a trajectory of robust growth, driven by technological advancements, the need for result standardization, and the continuous expansion of test portfolios. Despite challenges posed by pricing pressures, major players navigate these hurdles through strategic collaborations and innovative product offerings. The industry's commitment to addressing the rising burden of chronic diseases positions it as a critical player in advancing healthcare diagnostics on a global scale.

Exploring the Table of Contents: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=31517

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.